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1. Introduction 
GTP and more so its non-hydrolyzable analog 
GppNHp were found to be positive allosteric effecters 
of hormone activated adenylate cyclases in numerous 
systems [l-3] . Among the hormone activated 
adenylate cyclases which are synergistically activated 
by hormone and GppNHp is the catecholamine depen- 
dent adenylate cyclase of nucleated erythrocytes 
[4-81. Detailed kinetic analysis performed on the 
synergistic activation of turkey erythrocyte adenylate 
cyclase has demonstrated [7] that the hormone and 
GppNHp act in a synergistic fashion to bring about 
the formation of a permanently-active nzyme species. 
The activation process can be described according to 
the following scheme: 
R.E.GppNHp+H--- kl, If.R .GppNHp 
k2 
k3, H. R . E’ . GppNHp (1) 
where R is the hormone receptor, E the enzyme, H 
the hormone, E’ the permanently active species of 
the enzyme and k3 the rate constant characterizing 
the conversion of the inactive enzyme species to its 
active form E’. The @-species is insensitive to fl- 
adrenergic blockers such as propranolol and is perma- 
nently active [4-71. This rate constant, k3, was 
measured for the turkey erythrocyte catecholamine 
dependent adenylate cyclase and was found to be 
Abbrevhtions: GppNHp guanylylimidodiphosphate, CAMP 
adenosine 3’J’phosphate 
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k3 = 0.7 min-’ [7]. The specific activity of the 
enzyme in the presence of 1-epinephrine and Gpp- 
NHp is 8-fold higher than in the presence of GTP and 
1-epinephrine [6,7]. In view of the finding that turkey 
erythrocyte membranes possess a specific P-receptor- 
dependent GTPase [9] a general scheme describing both 
the activation of the adenylate cyclase by hormone and 
GTP and the termination of the hormonal signal was 
derived [lo] . This general scheme can be summarized 
in eq.2: 
kr 
R.E.GTP+H e H.R.E.GTPk3‘ 
kz 
H.R.E’.GTP~H.R.E+GDPtPi (2) 
where k3 describes the rate of enzyme activation and 
kq describes the rate of enzyme deactivation via the 
hormone-dependent GTPase step. From eq.2 it can 
be derived [lo] that in the presence of GTP the 
steady-state concentration of E’ is given by: 
E’zEO 
1 + k&a 
(3) 
where E, is the total enzyme concentration. It follows 
that E’ never exceeds 10-l 5% of E, since k4 was 
found to be ka = 4.0-6.0 min-’ [9]. When GppNHp 
is used instead of GTP, k4 = 0 and E’ equals E, and 
thus the specific activity measured in the presence of 
GppNHp is 7-lo-fold higher than in the presence of 
GTP [7,10] . To test this hypothesis a diagnostic 
experiment was designed. The experiment consists 
of the following: activation of the adenylate cyclase 
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by I-epinephrine + GppNHp to its &-state (eq.1). 
Then adding GTP which should replace GppNHp in 
the H .R . E’ . GppNHp species to form the 
He R . E’. GTP species. The latter species should then 
revert to H. R. E according to eq.2 and the low 
steady-state level of I? (eq.3) should be re-established. 
The net result of such an experiment would be the 
reversion of the permanently active state of the 
enzyme to its low, steady-state level of activity, in a 
hormone-dependent fashion. Such an experiment is 
the subject of this communication. Preliminary 
results from our laboratory already indicated [7] 
that ATP and 1-epinephrine are capable of reverting 
the permanently active enzyme to its low activity 
form. 
2. Materials and methods 
Turkey erythrocyte membranes were prepared as 
described earlier [ 111. Adenylate cyclase assay was 
performed as described by Salomon et al. [ 121. AU 
chemicals were of the highest analytical purity avail- 
able and all solutions were prepared using Corning 
double distilled water. 
3. Results 
3.1. The reversal of the GppNHp + I-epinephrine 
active-state by GTP 
The kinetics of reversal of the permanently active 
state induced by 1-epinephrine and GppNHp is shown 
in fig. 1. In this experiment the GppNHp + epine- 
I I 
IO 20 30 40 50 
800&_-+_.= 4 
IO 20 30 40 50 151 
J 
TIME OF INCUBATION , minutes 
Fig.1. The reversal of the permanently active cyclase to its inactive form by 1-epinephrine and GTP and by l-epinephrine and 
ATP. (A) Turkey erythrocyte membranes (1.8 mgjml) were preactivated by 0.1 mM l-epinephrine and 0.05 mM GppNHp in the 
presence of 0.05 M Tris-HCl, pH 7.4, containing 1.0 mM EDTA and 2.0 mM MgCl, in final vol. 10 ml for 40 min at 37”C, 
conditions sufficient to bring about full activation of the enzyme [7]. At the end of the incubation the incubation mixture was 
centrifuged at 20 000 X g for 15 min. Then the pellet was diluted into 10 ml 0.05 M Tri-HCl containing 1 mM EDTA and 3 
mM MgCl, and centrifuged at 20 000 X g for 15 min. The pellet was resuspended in the above buffer and recentrifuged. The 
process was repeated four times. Then the pellet was resuspended in 4.0 ml 0.05 M Tris-HCl buffer, pH 7.4, containing 1.0 mM 
EDTA, 4.0 mM MgCl, GTP, phosphoenolpyruvate (0.5 mg/ml) pyruvate kinase (20 units/ml), 5.0 mM KC1 and 0.1 mM 
1-epinephrine in the absence or in the presence of 2 X lo+ M DL-propranolol. At specified times the reversal process was stopped 
by withdrawing samples into an 0.05 M Tri-HCl buffer, pH 7.4, containing DL-propranolol to yield a final concentration of 
5.0 X 10e6M. The samples were washed four-times in Tris-MgCl,-EDTA buffer containing 5.0 X 10m6 M DL-propranolol and 
then assayed for adenylate cyclase activity in the presence of 5 X 10e6 M DL-propranolol. The enzyme preparation used in this 
experiment exhibited a specific activity of 80 + 5 pmol cAMP/mgjmin in the presence of 1.0 X 10e4 M 1-epinephrine and in the 
absence of GppNHp. (o-o-o) 1.0 X lo-’ M GTP + 1.0 X 10d4 M 1-epinephrine. (A-A-A) 5 X 10e4 M GTP + 1.0 X 10T4 M 
1-epinephrine. (w&o) 5 X lob4 M GTP + 1.0 X 10m4 M 1-epinephrine f 2 X 10e5 M DL-propranolol. (m-=-m) 5 X 10e4 M GTP 
alone. (B) Experimental details are identical to those described in A except that ATP rather than GTP was used as the reversing 
ligand. In this case 1 mM ATP and an ATP regenerating system consisting of 4.9 mg/ml creatine phosphate and 0.22 mg/ml 
creatine phosphokinase was used instead of GTP and GTP regenerating system. All other details in B are identical to those described 
in A. (o-*0) 1 mM ATP + 0.1 mM 1-epinephrine. (=-m-m) 1 mM ATP + 0.1 mM 1-epinephrine + 2.0 X lo-’ M DL-propranolol. 
(L&A) 1 mM ATP alone. 
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Table 1 
Reversal of the active-state to its inactive-state by purine nucleotides 
Ligands added Adenylate cyclase activity 
(pmol cAMP/mg/min) 
None 
1 mM AMP 
1 mM AMP + 0.1 mM 1-epinephrine 
1 mM GMP 
1 mM GMP + 0.1 mM 1-epinephrine 
1100 f 110 
1080 c 110 
915+ 60 
950 f 95 
5822 40 
0.1 mM ADP 
1 mM ADP 
0.1 mM ADP + 0.1 mM 1-epinephrine 
1 mM GDP 
0.1 mM GDP + 0.1 mM 1-epinephrine 
900 + 80 
880* 70 
785 + 60 
950? 60 
310+ 40 
0.1 mM 1-epinephrine alone 
1 mM ATP alone 
1 mM ATP + 0.1 mM 1-epinephrine 
0.5 mM GTP alone 
0.5 mM GTP + 0.1 mM 1-epinephrine 
1190 f 130 
1210 f 100 
200 f 30 
1150 + 120 
130+ 10 
Experimental conditions are identical to those described in the legend to fig.1. 
The incubation time was 40 min at 37°C. When GDP, ADP, GMP and AMP were 
tested as reversing ligands, no regenerating systems were added to avoid the 
formation of the triphosphates. All assays were performed in triplicates. The 
results are presented as values + SEM. 
phrine activated enzyme was incubated in the presence 
of saturating 1 -epinephrine and saturating GTP plus 
GTP regenerating system. Neither GTP alone nor 
1-epinephrine alone cause any reversal (fig.1, table 1). 
For the GTP experiments phosphoenolpyruvate plus 
pyruvate kinase was found to be a more effective GTP- 
regenerating system than phosphocreatine plus creatine 
kinase. The reversal kinetics were plotted on a semilog 
plot (fig.2). From fig.2 it can be seen that the process 
of reversal by GTP in the presence of hormone is a first- 
order process with a half-life of tJz = 4.9 min and one 
can calculate a first-order rate constant of krevetion = 
0.12 min-’ . This value probably corresponds to the rate 
of the GppNHp dissociation from the active H-R a_!? .
GppNHp complex (see Discussion). The fi-adrenergic 
blocker propranolol inhibits this reversal effect 
(fig.lA). 
3.2. The reversal of the GppNHp + I-epinephrine 
active-state by ATP 
ATP in the presence of I-epinephrine is also 
capable of reverting the permanently active-state of 
April 1977 
TIME, mmutes 
Fig.2. The first-order nature of the reversal process. Data of 
fig.lA and fig.lB are plotted on a semilogarithmic plot. The 
half-life of the activated state of the enzyme is t,/, = 4.9 
min which corresponds to a first-order rate constant k = 0.12 
min-‘. (o-o-o) 1.0 X lo-’ M GTP + 1.0 X 10e4 M l-epine- 
phrine. (~&-a) 5 X 10S4 GTP+ 1.0 X 10S4 M l-epinephrine. 
(***) 1 X lo-’ M ATP+ 1.0 X 10v4 M 1-epinephrine. 
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the enzyme to its low activity form (fig.1 B, table 1). 
ATP alone or 1 -epinephrine alone are incapable of 
inducing such an effect (fig.1 B, table 1). The concen- 
trations of ATP required to induce the reversal effect 
are two orders of magnitude higher than the concen- 
trations of GTP required to induce the same effect. 
As in the case of the GTP plus epinephrine induced 
effect the half-life of the reversal kinetics is tr/Z = 4.9 
min which is similar to the value observed for the 
GTP plus hormone-induced effect. As in the case of 
GTP, propranolol was found to inhibit the reversal 
reaction. Preliminary experiments [7] have already 
indicated to us that ATP in the presence of a hor- 
mone can revert the GppNHp plus hormone activated 
state to its lower activity form. 
3.3. The effects of ADP, GDP, AMPand GMPon 
the reversal reaction 
When enzyme pre-activated by 1 -epinephrine plus 
GppNHp is incubated in the presence of 1 mM ADP 
or 1 mM GDP in the presence of I-epinephrine, the 
enzyme is also partially reverted to its low activity 
level (table 1). GMP was found to be much less 
effective than the purine nucleoside disphosphates 
GDP and ADP (table 1). AMP was found to be com- 
pletely ineffective to bring about the reversal of the 
activated-state (table 1). All the experiments using the 
purine nucleoside diphosphates and nucleoside mono- 
phosphates were performed in the absence of a regene- 
rating system in order to avoid the formation of 
nucleoside triphosphates. 
3.4. The concerted nature of the GTP and hormone 
action 
When the highly active enzyme is incubated first 
with GTP (or ATP) and then with hormone or vice 
versa, no reversal occurs. Thus, both ligands must 
occupy their respective sites simultaneously in order 
for the reversal process to occur. 
4. Discussion 
4.1. The nature of the reversal process 
The 1 -epinephrine dependent adenylate cyclase 
of turkey erythrocyte can be activated to its per- 
manently active state, E’, by 1-epinephrine and 
GppNHp according to eq.1. In the presence of excess 
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GTP and hormone the enzyme can be induced to 
revert to its characteristic lower activity form. This 
phenomenon probably involves the displacement of 
GppNHp from its regulatory site by GTP which 
subsequently is hydrolyzed to GDP and Pi, provided 
the /I-adrenergic receptor is occupied by a P-agonist 
such as 1 -epinephrine. This process can be summarized 
in eq.4: 
Ha R. E’ .GppNHp, 
-GPPNH~~ R E’ +GTP \ 
+GppNHp * ’ ‘-GTP 
H.R.E+GDP (4) 
Thus, in the presence of excess GTP the characteristic 
steady-state level of active enzyme in the absence of 
GppNHp is re-established. This steady-state level is 
characterized by eq.3. The process of reversion in 
the presence of excess GTP is a first-order process as 
revealed by fig.2. It can be calculated that the rate 
constant characterizing the process is k = 0.12 min-’ . 
The subsequent step, namely the hormone-dependent 
GTPase step is fast (krl = 4.0-6.0 min-’ in eq.2) as 
was found by Cassel and Selinger [9] and therefore 
is not rate-limiting in the overall reversal process. 
Sequential exposure of the active enzyme to GTP 
and hormone or vice versa does not bring about the 
reversal process. Thus, the process of GppNHp 
dissociation from the GTP regulatory-site requires 
the presence of hormone. DL-Propranolol inhibits the 
conversion g--E (fig.1) which again demonstrates 
that both the hormone and the purine nucleotide 
must bind simultaneously to induce reversion. One 
may also conclude that the affinity of GppNHp 
within the H. R. E’ . GppNHp species is much lower 
than within the R. E’ . GppNHp species, since the 
sequential exposure of the activated enzyme to GTP 
and then to hormone does not lead to a reversion. 
The reversal of the highly active form of the enzyme 
to its low activity form can also be monitored using 
[3H] GppNHp. Cassel and Selinger [ 131 were indeed 
able recently to demonstrate that Lisoproterenol 
and GTP induce the release of 1 .O-2.0 pmol/mg 
membrane [3H]GppNHp. Since turkey erythrocyte 
membranes possess 1 .O-2.0 pmol/mg 8-adrenergic 
receptor [14,15] one may conclude that the stoi- 
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chiometry of hormone-receptor to GTP regulatory- 
sites is 1 .O-2.0. 
4.2. A TP as a reversing ligand 
ATP acts in a similar fashion to GTP (fig.1 B, 
fig.2 and table 1) but is effective at concentrations 
two orders of magnitude higher than the concentra- 
tion of GTP required to bring about the same effect. 
This may be due to the fact that all ATP preparations 
used are contaminated with GTP [ 161 and it is the 
latter which induces the reversal effects. It is still, 
however, possible that the effect is that of ATP which 
exhibits a much lower affinity to the GTP regulatory- 
site as compared to GTP. 
4.3. Purint: nucleoside diphosphates and mono- 
phosphates as reversing ligands 
GDP and ADP at high concentrations in the 
presence of 1-epinephrine can induce slowly the 
process of reversion (table 1). GMP in the presence 
of hormone was also found to induce slowly the 
conversion of the highly active form of the enzyme 
to its inactive form whereas AMP was completely 
ineffective (table 1). The fact that GDP and even 
GMP can induce the reversal of the highly active form 
of the enzyme to its low-activity form in the presence 
of hormone indicates that the GTPase step is not 
essential for the reversal step per se. The action of 
GDP or GMP as reversing ligands can be described 
by eq.5: 
-GPPNHP 
H. R. E’. GppNHp,LH- R 9 I? 
+ GPPNHP 
+ GDP 
;H.R-E’.GDP+H-R.E+GDP 
-GDP 
(5) 
Thus, the conversion of E’ to E does not require the 
GTPase step. The reversal process induced by GDP 
or GMP is slower than in the presence of GTP since 
probably the conversion of H. R. E’ . GDP to 
He R . E - GDP is slow and becomes rate-limiting. 
5. Conclusions 
The permanently active state of turkey erythrocyte 
adenylate cyclase induced by 1 -epinephrine and 
GppNHp can be reverted to its low-activity form, 
characteristic to that in the absence of GppNHp, by 
GTP and 1 -epinephrine. The process or reversal 
requires the simultaneous presence of GTP and a 
P-agonist and is blocked by the fl-adrenergic blocker 
propranolol. ATP, GDP and GMP can mimic the 
effect of GTP but less effectively. The process of 
reversal in the presence of saturating hormone and 
GTP is first-order with a rate constant of k = 0.12 
min-’ . This rate constant probably reflects the rate 
of GppNHp dissociation from the adenylate cyclase 
complex. The reversal process by GTP can be sum- 
marized by eq.6: 
k’4 
GTP_HeR*E*GTP%H*R’E+GDP+Pi(6) 
where kb is fast compared to k4 (the GTPase-step). 
The value of k\ is probably lower when nucleoside 
diphosphates and monophosphates are used. The fact 
that GTP is the most effective ligand inducing the 
reversion process indicates that it is probably the 
physiological ligand which controls the hormone 
activation of adenylate cyclase. 
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